JESSICA M MCCAFFERTY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FLORENCE, AL NPI 1962844183
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner AL Medtronic, Inc. All categories
General Payments — all program years on this page
$4,198.21
- Category: General Payments
- Program years: PY2021–2024
- Record count: 241
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $941.87 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $941.87 | 42 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $110.47 | 2 |
| Janssen Biotech, Inc. | $92.59 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $84.79 | 4 |
| Merck Sharp & Dohme Corporation | $62.49 | 3 |
| Stemline Therapeutics Inc. | $58.25 | 2 |
| Acerta Pharma LLC | $56.50 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $44.98 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.55 | 2 |
| Genentech USA, Inc. | $39.46 | 2 |
| Incyte Corporation | $38.88 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $38.81 | 2 |
| PFIZER INC. | $33.31 | 2 |
| Adaptive Biotechnologies Corporation | $31.73 | 2 |
| Celgene Corporation | $26.86 | 1 |
| Exelixis Inc. | $22.63 | 1 |
| Sumitomo Pharma America, Inc. | $22.14 | 1 |
| SOBI, INC | $21.74 | 1 |
| Lilly USA, LLC | $21.39 | 1 |
| ABBVIE INC. | $17.34 | 1 |
| Genmab U.S., Inc. | $17.09 | 1 |
| AVEO Pharmaceuticals, Inc. | $16.72 | 1 |
| BeiGene USA, Inc. | $15.44 | 1 |
| Rigel Pharmaceuticals, Inc. | $12.59 | 1 |
| Iovance Biotherapeutics, Inc. | $12.12 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.